Question follow-through · 119678
Liver Diseases: Medical Treatments
To ask the Secretary of State for Health and Social Care, what steps NHS England is taking, working with manufacturers of breakthrough treatments for fatty liver disease, to prepare the NHS to deliver such treatments as quickly as possible to eligible pat
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 10 Mar 2026
- Target answer date
- 12 Mar 2026
- Answer
- 19 Mar 2026 · 9 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Liver Diseases · 20 Mar 2026
- Alcoholic Drinks: Misuse · 20 Mar 2026
- Social Services: Armed Forces · 10 Jun 2026
- Social Services: Armed Forces · 10 Jun 2026
- Smoking · 1 Jul 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
10 Mar 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what steps NHS England is taking, working with manufacturers of breakthrough treatments for fatty liver disease, to prepare the NHS to deliver such treatments as quickly as possible to eligible pat
12 Mar 2026
Target answer date
Date supplied by the official written-questions record.
19 Mar 2026
Answer published
Newly licensed medicines are appraised by the National Institute for Health and Care Excellence (NICE), which is the independent body responsible for developing evidence-based guidance for the National Health Service on whether new medicines represent a c...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Liver Diseases
20 Mar 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the decision to cease updates to fatty liver disease data on Office for Health Improvement and Disparities Fingertips profiles on trends in th
Alcoholic Drinks: Misuse
20 Mar 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of a cross-government alcohol strategy.
Social Services: Armed Forces
10 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to prepare guidance on applying the Armed Forces Covenant Duty to adult social care.
Social Services: Armed Forces
10 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the merits of expanding existing NHS England funding for (a) national Armed Forces programmes and (b) staff training programmes on Armed Forces community awaren
Smoking
1 Jul 2026 · To ask the Secretary of State for Health and Social Care, whether smokefree 2030 remains his Department's target.
Smoking
1 Jul 2026 · To ask the Secretary of State for Health and Social Care, if he will publish a Roadmap to a Smokefree country to ensure that areas like Blackpool and Fleetwood, where smoking rates are higher than the national average, can support every smoker who wants t
Metabolic Dysfunction-associated Steatohepatitis
2 Jul 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to integrate steatotic liver disease indicators into non-communicable disease policy and frameworks to meet the World Health Assembly resolution on steatotic liv
Metabolic Dysfunction-associated Steatohepatitis
2 Jul 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of retiring the OHID Liver Disease Fingertips Profiles on the UK's ability to monitor steatotic liver disease indicators and meet the World Healt
Liver Diseases: Health Services
14 Sept 2026 · To ask the Secretary of State for Health and Social Care, what steps her Department is taking to reduce health inequalities in (a) liver disease and (b) liver cancer outcomes.